Ilay Caliskan, MD
RESIDENT
Pathology
School of Medicine

Publications (3)

Top publication keywords:
ReoperationSurvival RateVaccinationFemaleAdultIncidenceHumansSan FranciscoNeoplasm Recurrence, LocalSpinal Cord NeoplasmsHemangioblastomavon Hippel-Lindau DiseaseNeuromyelitis OpticaDatabases, FactualFollow-Up Studies

• Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations.
  Free neuropathology 2024 Caliskan I, Lu R, Szu Lyn Ding C, Sadala de Souza F, Perry A, Tihan T
• A Case With New-Onset Neuromyelitis Optica Spectrum Disorder Following COVID-19 mRNA BNT162b2 Vaccination.
  The neurologist 2022 Caliskan I, Bulus E, Afsar N, Altintas A
• Sporadic and Von-Hippel Lindau disease-associated spinal hemangioblastomas: institutional experience on their similarities and differences.
  Journal of neuro-oncology 2019 Yousef A, Rutkowski MJ, Yalcin CE, Eren OC, Caliskan I, Tihan T